Education
About Us
Working with TipRanks
Follow Us
AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
RESEARCH TOOLSreports
AFP Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$2.10 - AU$3.90
Previous CloseN/A
Volume204.00
Average Volume (3M)2.65K
Market Cap
AU$256.66M
Enterprise ValueAU$391.74M
Total Cash (Recent Filing)AU$10.69M
Total Debt (Recent Filing)$33.64M
Price to Earnings (P/E)24.1
Beta-0.07
Next Earnings
Nov 20, 2025EPS EstimateN/A
Next Dividend Ex-Date
Jun 18, 2025Dividend Yield0.59%
Share Statistics
EPS (TTM)0.12
Shares Outstanding104,866,260
10 Day Avg. Volume2,046
30 Day Avg. Volume2,647
Financial Highlights & Ratios
PEG Ratio-0.71
Price to Book (P/B)4.89
Price to Sales (P/S)0.00
P/FCF Ratio31.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
AFT Pharmaceuticals Ltd. News
PremiumCompany Announcements
AFT Pharmaceuticals Expands US Maxigesic Partnership with Hikma
PremiumCompany Announcements
AFT Pharmaceuticals Announces Dividend Distribution for 2025
PremiumCompany Announcements
AFT Pharmaceuticals Announces Final Dividend Distribution
PremiumCompany Announcements
AFT Pharmaceuticals Declares Final Dividend for 2025
PremiumCompany Announcements
AFT Pharmaceuticals Releases FY 2025 Investor PresentationPremiumCompany Announcements
AFT Pharmaceuticals Achieves Record Revenue and Expands Global Reach
PremiumCompany Announcements
AFT Pharmaceuticals Reports Revenue Growth Despite Profit DeclineOptions Prices
Currently, No data available
---
Ownership Overview
69.71% Insiders
―
Mutual Funds
― Other Institutional Investors
30.29% Public Companies and
Individual Investors
AFP FAQ
What was AFT Pharmaceuticals Ltd.’s price range in the past 12 months?
AFT Pharmaceuticals Ltd. lowest share price was AU$2.10 and its highest was AU$3.90 in the past 12 months.
What is AFT Pharmaceuticals Ltd.’s market cap?
AFT Pharmaceuticals Ltd.’s market cap is AU$256.66M.
When is AFT Pharmaceuticals Ltd.’s upcoming earnings report date?
AFT Pharmaceuticals Ltd.’s upcoming earnings report date is Nov 20, 2025 which is in 160 days.
How were AFT Pharmaceuticals Ltd.’s earnings last quarter?
AFT Pharmaceuticals Ltd. released its earnings results on May 21, 2025. The company reported AU$0.121 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.121.
Is AFT Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts AFT Pharmaceuticals Ltd.’s price is currently Overvalued.
Does AFT Pharmaceuticals Ltd. pay dividends?
AFT Pharmaceuticals Ltd. pays a Annually dividend of AU$0.014 which represents an annual dividend yield of 0.59%. See more information on AFT Pharmaceuticals Ltd. dividends here
What is AFT Pharmaceuticals Ltd.’s EPS estimate?
AFT Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AFT Pharmaceuticals Ltd. have?
AFT Pharmaceuticals Ltd. has 104,866,260 shares outstanding.
What happened to AFT Pharmaceuticals Ltd.’s price movement after its last earnings report?
AFT Pharmaceuticals Ltd. reported an EPS of AU$0.121 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.961%.
Which hedge fund is a major shareholder of AFT Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in AU:AFP
Company Description
AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals Limited develops, licenses, distributes, and sells pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, eyecare, first aid, pain management, gastrointestinal, dermatology, and medicated vitamins. The company was incorporated in 1997 and is headquartered in Auckland, New Zealand.